Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 – ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on...
Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...
Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic...
Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the...
L'administration de la dernière dose au dernier patient conclut l'étude de Phase 3 chez les personnes atteintes de diabète de Type 2, événement associé à un paiement de 10 millions de dollars de...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.53 | -8.70279146141 | 6.09 | 6.45 | 5.41 | 114767 | 5.84222597 | DE |
4 | -0.44 | -7.33333333333 | 6 | 6.88 | 5.41 | 87248 | 6.00816186 | DE |
12 | -2.28 | -29.0816326531 | 7.84 | 9.3 | 5.41 | 105469 | 6.78496298 | DE |
26 | 0.18 | 3.34572490706 | 5.38 | 10.96 | 5.11 | 115650 | 7.41430925 | DE |
52 | -4.74 | -46.0194174757 | 10.3 | 11.2 | 5.11 | 111009 | 7.79532402 | DE |
156 | -1.79 | -24.3537414966 | 7.35 | 16.16 | 2.745 | 96622 | 7.98305639 | DE |
260 | -7.48 | -57.3619631902 | 13.04 | 16.16 | 2.745 | 66333 | 8.09770757 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約